Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

231 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A novel type 2A von Willebrand factor mutation (V1499E) associated with variable clinical expression.
van den Heuvel E, de Laat B, Eckmann CM, Michiels JJ, Schneppenheim R, Budde U, van Mourik JA, Versteegh FG. van den Heuvel E, et al. J Pediatr Hematol Oncol. 2009 Apr;31(4):277-80. doi: 10.1097/MPH.0b013e31819d9119. J Pediatr Hematol Oncol. 2009. PMID: 19346881
A comparative analysis of different automated von Willebrand factor glycoprotein Ib-binding activity assays in well typed von Willebrand disease patients.
Vangenechten I, Mayger K, Smejkal P, Zapletal O, Michiels JJ, Moore GW, Gadisseur A. Vangenechten I, et al. Among authors: michiels jj. J Thromb Haemost. 2018 Jul;16(7):1268-1277. doi: 10.1111/jth.14145. Epub 2018 Jun 6. J Thromb Haemost. 2018. PMID: 29742318 Free article. Clinical Trial.
Acquired von Willebrand disease as a cause of recurrent mucocutaneous bleeding in primary thrombocythemia: relationship with platelet count.
van Genderen PJ, Michiels JJ, van der Poel-van de Luytgaarde SC, van Vliet HH. van Genderen PJ, et al. Ann Hematol. 1994 Aug;69(2):81-4. doi: 10.1007/BF01698487. Ann Hematol. 1994. PMID: 8080884
High-dose intravenous gammaglobulin therapy for acquired von Willebrand disease.
Van Genderen PJ, Papatsonis DN, Michiels JJ, Wielenga JJ, Stibbe J, Huikeshoven FJ. Van Genderen PJ, et al. Postgrad Med J. 1994 Dec;70(830):916-20. doi: 10.1136/pgmj.70.830.916. Postgrad Med J. 1994. PMID: 7532860 Free PMC article. Review.
231 results
Jump to page
Feedback